ERIK MORDUKHAYEV: Open Payments
NPI 1851464853 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$817 in 21 payments from 10 companies in 2025. Trend: 2023 $135 · 2024 $389 · 2025 $817
Food & beverage: $517Gift: $300
| Company | Payments | Amount |
|---|---|---|
| Celltrion, Inc. | 1 | $300 |
| Novo Nordisk Inc | 6 | $138 |
| Lilly USA, LLC | 4 | $107 |
| Astellas Pharma US Inc | 3 | $89 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $62 |
| PFIZER INC. | 1 | $25 |
| Corcept Therapeutics | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $22 |
Products named: Veozah, Rybelsus, MOUNJARO, Kerendia, Ozempic, NURTEC ODT, Korlym, ACCRUFER.
Industry payments across NY — which companies pay providers there.
